We are live on ! Find out more
TS

Third Security Portfolio holdings

AUM $241M Turnover 0%
1-Year Est. Return 45.43%
This Fund
S&P 500
This Quarter Est. Return
+33.42%
1 Year Est. Return
-45.43%
3 Year Est. Return
-28.24%
5 Year Est. Return
-58.7%
10 Year Est. Return
–
AUM
$849M
AUM Growth
+$179M
Cap. Flow
-$18.4M
Cap. Flow %
-2.17%
Top 10 Hldgs %
99.97%
Holding
12
New
–
Increased
1
Reduced
1
Closed
1
Avg Time Held
4.7 years
Top 10 Avg Time Held
3.2 years
Top 20 Avg Time Held
4.7 years

Top Buys

Rank Stock Value
1
PGEN icon
Precigen
PGEN
+$36.4M

Top Sells

Rank Stock Value
1
HALO icon
Halozyme
HALO
+$54.5M
2
TOVX icon
Theriva Biologics
TOVX
+$256K

Sector Composition

Rank Sector Weight
1 Healthcare 90.15%
2 Energy 6.54%
3 Consumer Staples 3.28%
4 Materials 0.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
PGEN icon
1
Precigen
PGEN
$2.37B
$571M 67.28%
74,553,246
+6,762,077
+10% +$36.4M
2013 Q3
23 quarters
HALO icon
2
Halozyme
HALO
$14B
$184M 21.68%
10,712,970
-3,379,801
-24% -$54.5M
2013 Q2
24 quarters
EPD icon
3
Enterprise Products Partners
EPD
$79.4B
$32.8M 3.86%
1,135,734
– –
2013 Q2
24 quarters
AQB icon
4
AquaBounty Technologies
AQB
$5.51M
$27.9M 3.28%
453,838
– –
2017 Q1
9 quarters
ET icon
5
Energy Transfer Partners
ET
$69.6B
$15.1M 1.78%
1,073,990
– –
2013 Q2
24 quarters
PTCT icon
6
PTC Therapeutics
PTCT
$5.11B
$6.19M 0.73%
137,551
– –
2018 Q3
3 quarters
NS icon
7
DELISTED
NuStar Energy L.P.
NS
$3.94M 0.46%
145,200
– –
2013 Q2
24 quarters
TCP
8
DELISTED
TC Pipelines LP
TCP
$3.65M 0.43%
97,000
– –
2013 Q2
24 quarters
FCSC
9
DELISTED
Fibrocell Science Inc.
FCSC
$3.14M 0.37%
1,653,486
– –
2013 Q2
24 quarters
OGEN icon
10
Oragenics
OGEN
$1.94M
$759K 0.09%
860
– –
2013 Q2
24 quarters
KWR icon
11
Quaker Houghton
KWR
$2.68B
$262K 0.03%
1,290
– –
2018 Q3
3 quarters
TOVX icon
12
Theriva Biologics
TOVX
$9.5M
– –
-1,513
Closed -$256K –

Similar funds

KRC
Kehrs Ridge Capital Holmdel, New Jersey $260M AUM 0.46% 1-Year Est. Return
A
Apoletto Road Town, Tortola, British Virgin Islands $260M AUM 31.4% 1-Year Est. Return
AIA
AGF Investments America Toronto, Ontario, Canada $271M AUM 7.04% 1-Year Est. Return
FG
Foundry Group Boulder, Colorado $209M AUM 47.6% 1-Year Est. Return
RFA
Radnor Financial Advisors Wayne, Pennsylvania $284M AUM 23.21% 1-Year Est. Return
UIA
UBP Investment Advisors Geneva, Switzerland $194M AUM 12.96% 1-Year Est. Return
GCM
Gabalex Capital Management New York $181M AUM 9.55% 1-Year Est. Return
GMA
Goldstein Munger & Associates San Ramon, California $303M AUM 19.66% 1-Year Est. Return

Third Security's Q2 2019 Portfolio in Review

As of Q2 2019, Third Security held 12 positions worth $849M, up 27% from $670M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Third Security's Q2 2019 filing shows 1 increased, 1 reduced and 1 closed positions. The largest sale was Halozyme, an estimated $54.5M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 88% a quarter earlier, followed by Energy and Consumer Staples.

  • Third Security added most to Precigen in Q2 2019, an estimated $36.4M increase.
  • Third Security's biggest Q2 2019 reduction was Halozyme, cutting an estimated $54.5M.
  • Third Security fully exited Theriva Biologics in Q2 2019, selling an estimated $256K.
  • Third Security's ten largest holdings make up 100% of its $849M portfolio in Q2 2019.
  • Third Security opened 0 new positions and closed 1 in Q2 2019.
  • Third Security's portfolio value rose 27% quarter-over-quarter to $849M.

Based on Third Security's 13F filing for Q2 2019, filed 9 Aug 2019.